Last updated: July 29, 2025
Introduction
Patent KR20160104747, granted in South Korea, centers around innovative advancements in pharmaceutical compositions or methods. To understand its strategic importance, a thorough examination of its scope, claims, and broader patent landscape is imperative. This analysis aims to clarify the patent's breadth, explore its scope within the industry, and contextualize its position amidst competing patents, setting a foundation for strategic decision-making within pharmaceutical R&D and licensing.
Patent Scope and Claims
Scope Overview
KR20160104747's scope predominantly revolves around the specific composition, formulation, or method disclosed. The claims define the boundary of the patent's legal protection, indicating what is protected and to what extent. Typically, drug patents encompass claims covering:
- The active pharmaceutical ingredient (API) itself.
- Unique formulations or delivery systems.
- Manufacturing processes.
- Therapeutic methods or indications.
Claim Structure and Analysis
The patent's claims are classified into independent and dependent types.
-
Independent Claims:
These form the broadest protective scope and identify the core invention—often the chemical structure of the API, the novel formulation, or the method of treatment. For example, a typical independent claim might claim a pharmaceutical composition comprising a specific API with particular excipients or a novel administration method with improved bioavailability.
-
Dependent Claims:
These narrow the independent claims by adding specific features or limitations, such as dosage ranges, specific combinations, or manufacturing parameters.
Claim Language & Interpretation
The language of the claims in KR20160104747 likely employs precise chemical and procedural terminology. In the South Korean patent system, claims are interpreted with a focus on literal meaning but must be carefully examined for scope and potential ambiguity. Courts tend to interpret claims broadly to prevent infringing activities but with specificity to avoid undue extension.
Key Elements of the Patent Claims
Based on typical pharmaceutical patents with similar scopes, the claims may include:
- Chemical Structure: Novel derivatives or analogs of known drugs with improved efficacy or reduced side effects.
- Formulation Features: Nano-formulations, controlled-release systems, or unique carriers.
- Method of Use: Specific therapeutic applications, such as treating a particular disease or condition.
- Manufacturing Process: Innovative synthesis or encapsulation techniques.
The sufficient breadth of these claims determines the patent's competitiveness, affecting licensing opportunities and patent litigation risks.
Patent Landscape and Competitive Positioning
1. Global and Regional Patent Strategy
KR20160104747 sits within a complex patent environment. South Korea's established pharmaceutical patent landscape mirrors global trends, notably in biosimilars, small molecules, and delivery systems. The patent office's recent emphasis on biopharmaceutical innovations indicates active patent filing around biologics and targeted therapies.
2. Relevant Patent Families and Similar Patents
Analyzing related patents, both within South Korea and internationally, reveals overlapping claims or complementary technologies. For instance:
- Patent families targeting similar chemical scaffolds or delivery methods.
- Cross-licensing opportunities or potential patent conflicts.
- International patent filings in major jurisdictions (e.g., WO, US, EP) that collaborate with the Korean patent.
3. Prior Art and Patentability
The patent was likely granted after a thorough examination confirming novelty and inventive step over prior art. However, existing disclosures, such as earlier patents or scientific publications citing the same or similar compounds/methods, form the basis for possible oppositions or invalidation efforts.
4. Freedom to Operate (FTO) Considerations
Companies utilizing or commercializing the technology must assess the possibility of infringing other active patents in Korea, especially given the densely populated patent landscape for drug innovations. A detailed patent landscape mapping indicates that while KR20160104747 offers a certain scope, overlapping rights could pose FTO challenges for broader applications.
Legal and Strategic Implications
-
Protection Duration:
As a utility patent, the protection typically extends 20 years from the filing date, subject to maintenance fees. This period defines the window for exclusive commercialization.
-
Potential for Patent Thickets:
The proliferation of similar patents may create "patent thickets" that hinder freedom to operate, particularly in complex therapeutic areas like oncology or biologics.
-
Licensing and Out-Licensing Opportunities:
The patent's strategic value amplifies if it covers a novel API or formulation in high-demand therapeutic areas, making it attractive for partners or licensors.
-
Risk of Patent Infringement Litigation:
Given overlapping claims with other patents, litigation or patent office oppositions are plausible risk factors, especially in the competitive Korean biopharma ecosystem.
Conclusion
KR20160104747 features a carefully delineated scope primarily geared toward a novel pharmaceutical composition or method, with claims tailored to establish a broad but defensible monopoly. Its positioning within the South Korean patent landscape underscores competitive strength in targeted therapeutic areas but necessitates vigilance against potential patent overlaps and challenges. A strategic approach should involve comprehensive freedom-to-operate analysis, ongoing monitoring of competitors’ patent filings, and exploration of licensing pathways to maximize the patent's commercial value.
Key Takeaways
- The patent’s claims likely encompass both specific chemical compositions and method-of-use claims, defining a strategic intellectual property position.
- A thorough patent landscape analysis reveals potential overlaps that could influence licensing and enforcement strategies.
- Maintaining patent strength requires active monitoring of related patent filings and a plan to defend against potential oppositions.
- The scope of claims dictates the patent's ability to prevent competitors from entering or challenging the market.
- Strategic licensing or partnerships can capitalize on the patent's protected scope, particularly if it covers high-value therapeutic innovations.
FAQs
Q1: How broad are the claims of KR20160104747 compared to similar drug patents?
A1: The claims are designed to balance broad coverage for core innovations, such as a novel API or formulation, with specificity to withstand prior art challenges. Typically, they are narrower than broad chemical class claims but sufficiently comprehensive to protect significant therapeutic advancements.
Q2: Can KR20160104747 be challenged based on existing prior art?
A2: Yes, any prior publication or patent disclosing similar compounds, methods, or formulations could be grounds for an invalidity challenge, but the granted status indicates it passed novelty and inventive step criteria at the time.
Q3: What is the likelihood of this patent facing infringement litigation?
A3: If the patent covers a commercially valuable drug candidate, infringement risks increase, especially as competitors seek to develop similar products. Proper freedom-to-operate analysis is essential to mitigate this risk.
Q4: How does the patent landscape impact licensing opportunities?
A4: A well-defined patent scope can attract licensing partners seeking exclusivity in specific therapeutic areas, providing revenue streams and strategic alliances.
Q5: Will this patent protect biologic drugs or small molecules?
A5: The scope depends on the claims' language; generally, small-molecule patents focus on chemical structures, whereas biologics involve complex manufacturing claims. A detailed review of the claims would clarify this further.
References
[1] Korean Intellectual Property Office (KIPO). KR20160104747 Patent Document, 2016.
